Mastitis medical therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Bot: Removing from Primary care)
 
(9 intermediate revisions by 4 users not shown)
Line 5: Line 5:
==Overview==
==Overview==


Supportive care is the mainstay of therapy for puerperal mastitis. Supportive therapy includes [[massage]], heat application, cold compresses and frequent breastfeeding.  The treatment for non-puerperal mastitis is based on the underlying condition.  Pharmacological therapies for non-puerperal mastitis include [[prolactin]] inhibiting agents, antimicrobial therapy, and [[nonsteroidal anti-inflammatory drugs]] (NSAIDs).  Granulomatous mastitis has been treated with some success by a combination of steroids and [[prolactin]] inhibiting medications.
Supportive care is the mainstay of therapy for puerperal mastitis. Supportive therapy includes [[massage]], heat application, cold compresses, pain-relief and frequent [[breastfeeding]].  The treatment for non-puerperal mastitis is based on the underlying condition.  Pharmacological therapies for non-puerperal mastitis include [[prolactin]] inhibiting agents, antimicrobial therapy, and [[nonsteroidal anti-inflammatory drugs]] ([[NSAIDs]]).  [[Granulomatous]] mastitis has been treated with some success by a combination of steroids and [[prolactin]] inhibiting medications.


==Medical Therapy==
==Medical Therapy==


===Puerperal Mastitis===
===Puerperal Mastitis===
* Supportive care is the mainstay of therapy for puerperal mastitis. Supportive therapy includes [[massage]], heat application, cold compresses, pain-relief and frequent [[breastfeeding]].


[[Massage]] and the application of heat can help prior to feeding as this will aid the opening of the ducts and passageways.  A cold compress may be used to ease the pain when not wanting to lose the milk, though it is most appropriate to reduce the levels of milk contained.  For this reason it is also advised that the baby should frequently feed from the inflamed breast.  However, the content of the milk may be slightly altered, sometimes being more salty, and the taste may make the baby reject the breast at the first instance.
*[[Massage]] and the application of heat can help prior to feeding as this will aid the opening of the ducts and passageways.  A cold compress may be used to ease the pain when not wanting to lose the [[milk]], though it is most appropriate to reduce the levels of [[milk]] contained.  For this reason it is also advised that the baby should frequently feed from the [[inflamed]] [[breast]].  However, the content of the [[milk]] may be slightly altered, sometimes being more salty, and the taste may make the baby reject the [[breast]] at the first instance.


The presence of cracks or sores on the nipples increases the likelihood of [[infection]].  Tight clothing or ill-fitting bras may also cause problems as they compress the breasts.  The most common infecting organism is ''[[Staphylococcus aureus|Staph. aureus]]'', and babies carrying the organism in their noses are more likely to give it to their mothers;<ref>{{cite journal | title=A case-control study of mastitis: nasal carriage of ''Staphylococcus aureus'' | author=Amir LH, Garland SM, Lumley J. | journal=BMC Family Practice. | year=2006 | volume=7 | pages=57 |    doi=10.1186/1471-2296-7-57}}</ref> the clinical significance of this finding is still unknown, but theoretically, removing carriage from the nursing infant's nose may help prevent recurrence.
*In severe cases it may be required to stop [[lactation]] and use lactation inhibiting medication.
 
In severe cases it may be required to stop [[lactation]] and use lactation inhibiting medication.


===Non-puerperal Mastitis===
===Non-puerperal Mastitis===
The treatment for non-puerperal mastitis is based on the underlying condition.  Pharmacological therapies for non-puerperal mastitis include [[prolactin]] inhibiting agents, antimicrobial therapy, and [[nonsteroidal anti-inflammatory drugs]] ([[NSAIDs]])
*[[Prolactin]] inhibiting medication has been shown to be most effective and reduce risk of recurrence.<ref name="pmid8188014">{{cite journal| author=Pahnke VG, Goepel E| title=[Non-puerperal mastitis: a disease without end? (Results of a long-term study)]. | journal=Geburtshilfe Frauenheilkd | year= 1994 | volume= 54 | issue= 3 | pages= 155-60 | pmid=8188014 | doi=10.1055/s-2007-1023572 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8188014  }} </ref><ref name="pmid2040409">{{cite journal| author=Goepel E, Pahnke VG| title=[Successful therapy of nonpuerperal mastitis--already routine or still a rarity?]. | journal=Geburtshilfe Frauenheilkd | year= 1991 | volume= 51 | issue= 2 | pages= 109-16 | pmid=2040409 | doi=10.1055/s-2007-1023685 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2040409  }} </ref>


Treatment according to presumed cause, diagnosis and treatment of underlying condition is very important.
*[[Antibiotics]] should be given in addition to [[prolactin]] inhibiting medication if there are clear signs of [[infection]].


[[Prolactin]] inhibiting medication has been shown to be most effective and reduce risk of recurrence (Goepel & Pahnke 1991, Krause et al 1994, Stauber & Weyerstrahl 2005, Petersen 2003, Goerke et al 2003).
*[[Granulomatous]] mastitis has been treated with some success by a combination of [[steroid]]s and [[prolactin]] inhibiting medication.


[[Antibiotics]] should be given in addition to [[prolactin]] inhibiting medication if there are clear signs of [[infection]].
*More exotic treatments for non-puerperal mastitis that have been mentioned to show at least some efficacy include local and systemic [[progestins]] or [[progesterone]] <ref name="pmid8188014">{{cite journal| author=Pahnke VG, Goepel E| title=[Non-puerperal mastitis: a disease without end? (Results of a long-term study)]. | journal=Geburtshilfe Frauenheilkd | year= 1994 | volume= 54 | issue= 3 | pages= 155-60 | pmid=8188014 | doi=10.1055/s-2007-1023572 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8188014  }} </ref><ref name="pmid2040409">{{cite journal| author=Goepel E, Pahnke VG| title=[Successful therapy of nonpuerperal mastitis--already routine or still a rarity?]. | journal=Geburtshilfe Frauenheilkd | year= 1991 | volume= 51 | issue= 2 | pages= 109-16 | pmid=2040409 | doi=10.1055/s-2007-1023685 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2040409  }} </ref>, and [[Danazol]].


[[Granulomatous]] mastitis has been treated with some success by a combination of [[steroid]]s and [[prolactin]] inhibiting medication.
*[[NSAIDs]] are being used to treat symptoms of the [[inflammation]], however it must be considered that these medications also affect [[pituitary]] function and tend to increase [[prolactin]] and [[IGF-1]] levels


More exotic treatments for non-puerperal mastitis that have been mentioned to show at least some efficacy include local and systemic [[Progestins]] or [[Progesterone]] (Goepel & Pahnke 1991), antidiuretics, Vitex Agnus Castus extract and Danazol.
*Many variants of surgical procedures such as duct resection have been tried to reduce the risk of recurrent subareolar [[abscess]]es. So far the success rates are limited and conservative treatment seems preferable where possible.
 
*Approximately 30% of cases develop chronic or recurring mastitis requiring long term or indefinite treatment with [[prolactin]] inhibiting medication.<ref name="pmid8188014">{{cite journal| author=Pahnke VG, Goepel E| title=[Non-puerperal mastitis: a disease without end? (Results of a long-term study)]. | journal=Geburtshilfe Frauenheilkd | year= 1994 | volume= 54 | issue= 3 | pages= 155-60 | pmid=8188014 | doi=10.1055/s-2007-1023572 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8188014  }} </ref><ref name="pmid2040409">{{cite journal| author=Goepel E, Pahnke VG| title=[Successful therapy of nonpuerperal mastitis--already routine or still a rarity?]. | journal=Geburtshilfe Frauenheilkd | year= 1991 | volume= 51 | issue= 2 | pages= 109-16 | pmid=2040409 | doi=10.1055/s-2007-1023685 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2040409  }} </ref>
[[NSAIDs]] are being used to treat symptoms of the [[inflammation]], however it must be considered that these medications also affect [[pituitary]] function and tend to increase [[prolactin]] and [[IGF-1]] levels (Caviezel et al 1983).
 
Many variants of surgical procedures such as duct resection have been tried to reduce the risk of recurrent subareolar [[abscess]]es. So far the success rates are limited and conservative treatment seems preferable where possible (Petersen 2003, Hannavadi et al 2005).
 
Approximately 30% of cases develop chronic or recurring mastitis requiring long term or indefinite treatment with [[prolactin]] inhibiting medication (Goerke et al 2003).


===Granulomatous mastitis===
===Granulomatous mastitis===


Steroid is the treatment of choice with or without [[prolactin]] inhibiting medications although a gold standard treatment modality has not been well established.<ref name="pmid26148520">{{cite journal| author=Altintoprak F, Kivilcim T, Yalkin O, Uzunoglu Y, Kahyaoglu Z, Dilek ON| title=Topical Steroids Are Effective in the Treatment of Idiopathic Granulomatous Mastitis. | journal=World J Surg | year= 2015 | volume= 39 | issue= 11 | pages= 2718-23 | pmid=26148520 | doi=10.1007/s00268-015-3147-9 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26148520}}</ref><ref name="pmid24446305">{{cite journal| author=Zhang LN, Shi TY, Yang YJ, Zhang FC| title=An SLE patient with prolactinoma and recurrent granulomatous mastitis successfully treated with hydroxychloroquine and bromocriptine. | journal=Lupus | year= 2014 | volume= 23 | issue= 4 | pages= 417-20 | pmid=24446305 | doi=10.1177/0961203313520059 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24446305}}</ref>
*[[Steroid]] is the treatment of choice with or without [[prolactin]] inhibiting medications although a gold standard treatment modality has not been well established.<ref name="pmid26148520">{{cite journal| author=Altintoprak F, Kivilcim T, Yalkin O, Uzunoglu Y, Kahyaoglu Z, Dilek ON| title=Topical Steroids Are Effective in the Treatment of Idiopathic Granulomatous Mastitis. | journal=World J Surg | year= 2015 | volume= 39 | issue= 11 | pages= 2718-23 | pmid=26148520 | doi=10.1007/s00268-015-3147-9 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26148520}}</ref><ref name="pmid24446305">{{cite journal| author=Zhang LN, Shi TY, Yang YJ, Zhang FC| title=An SLE patient with prolactinoma and recurrent granulomatous mastitis successfully treated with hydroxychloroquine and bromocriptine. | journal=Lupus | year= 2014 | volume= 23 | issue= 4 | pages= 417-20 | pmid=24446305 | doi=10.1177/0961203313520059 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24446305}}</ref>


Metothrexate and azathioprine can be added to maintain remission.<ref name="pmid21966829">{{cite journal| author=Peña-Santos G, Ruiz-Moreno JL| title=[Idiopathic granulomatous mastitis treated with steroids and methotrexate]. | journal=Ginecol Obstet Mex | year= 2011 | volume= 79 | issue= 6 | pages= 373-6 | pmid=21966829 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21966829}}</ref>
*[[Methotrexate]] and [[azathioprine]] can be added to maintain [[remission]].<ref name="pmid21966829">{{cite journal| author=Peña-Santos G, Ruiz-Moreno JL| title=[Idiopathic granulomatous mastitis treated with steroids and methotrexate]. | journal=Ginecol Obstet Mex | year= 2011 | volume= 79 | issue= 6 | pages= 373-6 | pmid=21966829 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21966829}}</ref>


===Antimicrobial regimen===
===Antimicrobial regimen===
Line 53: Line 49:
==References==
==References==
{{reflist|2}}
{{reflist|2}}
{{WH}}
{{WS}}


[[Category:Dermatology]]
[[Category:Dermatology]]
[[Category:Emergency mdicine]]
[[Category:Disease]]
[[Category:Up-To-Date]]
[[Category:Infectious disease]]
[[Category:Infectious disease]]
[[Category:Primary care]]
[[Category:Gynecology]]
 
[[Category:Surgery]]
{{WH}}
{{WS}}

Latest revision as of 22:38, 29 July 2020

Mastitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Mastitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Case Studies

Case #1

Mastitis medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Mastitis medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Mastitis medical therapy

CDC on Mastitis medical therapy

Mastitis medical therapy in the news

Blogs on Mastitis medical therapy

Directions to Hospitals Treating Mastitis

Risk calculators and risk factors for Mastitis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Prince Tano Djan, BSc, MBChB [2]

Overview

Supportive care is the mainstay of therapy for puerperal mastitis. Supportive therapy includes massage, heat application, cold compresses, pain-relief and frequent breastfeeding. The treatment for non-puerperal mastitis is based on the underlying condition. Pharmacological therapies for non-puerperal mastitis include prolactin inhibiting agents, antimicrobial therapy, and nonsteroidal anti-inflammatory drugs (NSAIDs). Granulomatous mastitis has been treated with some success by a combination of steroids and prolactin inhibiting medications.

Medical Therapy

Puerperal Mastitis

  • Supportive care is the mainstay of therapy for puerperal mastitis. Supportive therapy includes massage, heat application, cold compresses, pain-relief and frequent breastfeeding.
  • Massage and the application of heat can help prior to feeding as this will aid the opening of the ducts and passageways. A cold compress may be used to ease the pain when not wanting to lose the milk, though it is most appropriate to reduce the levels of milk contained. For this reason it is also advised that the baby should frequently feed from the inflamed breast. However, the content of the milk may be slightly altered, sometimes being more salty, and the taste may make the baby reject the breast at the first instance.
  • In severe cases it may be required to stop lactation and use lactation inhibiting medication.

Non-puerperal Mastitis

The treatment for non-puerperal mastitis is based on the underlying condition. Pharmacological therapies for non-puerperal mastitis include prolactin inhibiting agents, antimicrobial therapy, and nonsteroidal anti-inflammatory drugs (NSAIDs)

  • Prolactin inhibiting medication has been shown to be most effective and reduce risk of recurrence.[1][2]
  • More exotic treatments for non-puerperal mastitis that have been mentioned to show at least some efficacy include local and systemic progestins or progesterone [1][2], and Danazol.
  • Many variants of surgical procedures such as duct resection have been tried to reduce the risk of recurrent subareolar abscesses. So far the success rates are limited and conservative treatment seems preferable where possible.
  • Approximately 30% of cases develop chronic or recurring mastitis requiring long term or indefinite treatment with prolactin inhibiting medication.[1][2]

Granulomatous mastitis

  • Steroid is the treatment of choice with or without prolactin inhibiting medications although a gold standard treatment modality has not been well established.[3][4]

Antimicrobial regimen

References

  1. 1.0 1.1 1.2 Pahnke VG, Goepel E (1994). "[Non-puerperal mastitis: a disease without end? (Results of a long-term study)]". Geburtshilfe Frauenheilkd. 54 (3): 155–60. doi:10.1055/s-2007-1023572. PMID 8188014.
  2. 2.0 2.1 2.2 Goepel E, Pahnke VG (1991). "[Successful therapy of nonpuerperal mastitis--already routine or still a rarity?]". Geburtshilfe Frauenheilkd. 51 (2): 109–16. doi:10.1055/s-2007-1023685. PMID 2040409.
  3. Altintoprak F, Kivilcim T, Yalkin O, Uzunoglu Y, Kahyaoglu Z, Dilek ON (2015). "Topical Steroids Are Effective in the Treatment of Idiopathic Granulomatous Mastitis". World J Surg. 39 (11): 2718–23. doi:10.1007/s00268-015-3147-9. PMID 26148520.
  4. Zhang LN, Shi TY, Yang YJ, Zhang FC (2014). "An SLE patient with prolactinoma and recurrent granulomatous mastitis successfully treated with hydroxychloroquine and bromocriptine". Lupus. 23 (4): 417–20. doi:10.1177/0961203313520059. PMID 24446305.
  5. Peña-Santos G, Ruiz-Moreno JL (2011). "[Idiopathic granulomatous mastitis treated with steroids and methotrexate]". Ginecol Obstet Mex. 79 (6): 373–6. PMID 21966829.
  6. Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL; et al. (2014). "Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America". Clin Infect Dis. 59 (2): 147–59. doi:10.1093/cid/ciu296. PMID 24947530.

Template:WH Template:WS